Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGS AS ANTIHERPETIC AGENTS

  • Read more about CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGS AS ANTIHERPETIC AGENTS
US Patent 5,840,728
Filed on 1997-08-07

THERAPEUTIC CHEMOKINE ANTAGONISTS

  • Read more about THERAPEUTIC CHEMOKINE ANTAGONISTS
Patent Cooperation Treaty
PCT/US1997/015594
Filed on 1997-09-05

I AND I LABELED PHOSPHOLIPIDS

  • Read more about I AND I LABELED PHOSPHOLIPIDS
US Patent 4,571,332
Filed on 1982-09-19

PHASE-DISPLAY OF IMMUNOGLOBIN HEAVY CHAIN LIBRARIES FOR IDENTIFICATION OF INHIBIOTRS OF INTRACELLULAR CONSTITUENTS

  • Read more about PHASE-DISPLAY OF IMMUNOGLOBIN HEAVY CHAIN LIBRARIES FOR IDENTIFICATION OF INHIBIOTRS OF INTRACELLULAR CONSTITUENTS
US Patent 5,824,520
Filed on 1997-07-18

O-MALONYL TYROSYL-CONTAINING SH2 DOMAIN INHIBITORS

  • Read more about O-MALONYL TYROSYL-CONTAINING SH2 DOMAIN INHIBITORS
US Application 08/914,060
Filed on 1997-07-15

Human Papilloma Virus Anti-Sense Oligonucleotides

  • Read more about Human Papilloma Virus Anti-Sense Oligonucleotides
US Patent 6,084,090
Filed on 1997-09-05

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING SKIN TUMOR FORMATION AND CAUSING REGRESSION OF EXISTING TUMORS

  • Read more about PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING SKIN TUMOR FORMATION AND CAUSING REGRESSION OF EXISTING TUMORS
US Application 08/876,510
Filed on 1997-06-16

TREATED BIRDSEED PREFERENTIALLY PALATABLE TO BIRDS BUT NOT PALATABLE TO ANIMALS HAVING CAPSAICIN SENSITIVE RECEPTORS

  • Read more about TREATED BIRDSEED PREFERENTIALLY PALATABLE TO BIRDS BUT NOT PALATABLE TO ANIMALS HAVING CAPSAICIN SENSITIVE RECEPTORS
US Patent 5,879,696
Filed on 1997-06-12

METHOD FOR INDUCING MONOCYTES TO EXHIBIT THE PHENOTYPE OF ACTIVATED MYELOID DENDRITIC CELLS

  • Read more about METHOD FOR INDUCING MONOCYTES TO EXHIBIT THE PHENOTYPE OF ACTIVATED MYELOID DENDRITIC CELLS
US Patent 6,010,905
Filed on 1997-06-30

Methods and Compositions for Stimulating and Inhibiting TGF-B Activity with regulatory

  • Read more about Methods and Compositions for Stimulating and Inhibiting TGF-B Activity with regulatory
US Patent 6,384,189
Filed on 1997-06-10

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1543
  • Page 1544
  • Page 1545
  • Page 1546
  • Page 1547
  • Page 1548
  • Page 1549
  • Page 1550
  • Page 1551
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health